Director/PDMR Shareholding
Notification of Transactions of Directors and Persons Discharging Managerial Responsibility
2009 GlaxoSmithKline Performance Share Plan - 2008 Award
Sale of shares to meet tax liability
I give below details of changes in the interests of:
Directors and Persons Discharging Managerial Responsibility in the Ordinary shares of GlaxoSmithKline plc in respect of the under mentioned persons arising from the sale of Ordinary shares at a price of £11.77 per Ordinary Share on 25 February 2011 to meet their tax liabilities following the vesting of a Performance Share Plan (PSP) award:
|
|
No. of Ordinary shares sold to meet tax liabilities following the vesting of a PSP award |
|
Mr A Witty* |
58,532 |
|
Mr J S Heslop* |
21,468 |
|
Mr S M Bicknell |
908 |
|
Mr J M Clarke |
15,743 |
|
Mr M Dunoyer |
3,779 |
|
Mr E J Gray |
10,223 |
|
Mr D S Redfern |
1,207 |
|
Ms C Thomas |
908 |
|
Mr P Vallance |
3,748 |
* Denotes an Executive Director
Persons Discharging Managerial Responsibility in the American Depositary Shares (ADSs) of GlaxoSmithKline plc in respect of the under mentioned persons arising from the withholding of shares at a price of $38.13 per ADS on 25 February 2011 to meet their tax liabilities following the vesting of a Performance Share Plan award:
|
|
No. of ADSs withheld to meet tax liabilities following the vesting of a PSP award |
|
Dr M M Slaoui* |
10,549 |
|
Mr W C Louv |
3,258 |
|
Mr D Pulman |
3,258 |
* Denotes an Executive Director
The Company, Directors, Persons Discharging Managerial Responsibility were advised of these transactions on 1 March 2011.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
1 March 2011
This information is provided by RNS